drugset / Trial / NCT06231355

Liposomal vs. Conventional Bupivacaine for Pain Control

NCT06231355 ↗

Phase 4 Completed 61 enrolled Peking University First Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this pilot study is to test the hypothesis that liposomal bupivacaine extends the duration of paravertebral block in patients undergoing radical nephrectomy, achieving improved analgesia compared to conventional bupivacaine. The main questions it aims to answer are: * Area under curve of numeric rating scale of pain from 12 to 72 h after surgery. * Cumulative opioid consumption during the period of 12 to 72 h after surgery.

Timeline

Start
2024-02-21
Primary completion
2024-09-09
Completion
2024-10-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — —

Indications

No indication recorded.